Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-012-2 | CAS number: 137296-15-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2005-05-18 to 2005-06-30
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- fixed dose procedure
- Limit test:
- no
Test material
- Reference substance name:
- Propanoic acid, 2-hydroxy-, ammonium salt (1:1), (2S)-
- EC Number:
- 604-012-2
- Cas Number:
- 137296-15-2
- Molecular formula:
- C3H9O3N
- IUPAC Name:
- Propanoic acid, 2-hydroxy-, ammonium salt (1:1), (2S)-
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Ammonium Lactate, PURASAL® NH
- Physical state: liquid
- Analytical purity: not reported
- Lot/batch No.: 0503002615
- Expiration date of the lot/batch: 2007-09-28
- Storage condition of test material: room temperature (20 +/- 5 °C) in the dark
- Other: Reception date: 2005-09-28
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Interfauna Ibérica, S.L., Barcelona, Spain
- Age at study initiation: ca. 9 weeks (animals were ca. 8 weeks at arrival at the test facility and underwent a 7 day acclimatisation period prior to study initiation)
- Weight at study initiation: preliminary study (2 animals): 207 and 218 g; main study (5 animals): 206-221 g
- Fasting period before study: 17-18 h prior to administration
- Housing: Makrolon cages with Ultrasorb sawdust bedding (Panlab S.L.); each cage contained a maximum of 5 animals of the same sex and administration group; the sawdust bedding was replaced by a metal grille during the period of fasting previous to administration
- Identification of animals: individual indentification by code using an ear-punch technique
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-24
- Humidity (%): 45-70
- Air changes (per hr): not reported
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 200 mg/mL
- Lot/batch no. (if required): 5133B02
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg bw - Doses:
- Preliminary study:
The test item was administered orally to two females. Initially, one rat was treated at the dose of 300 mg/kg bw. As neither mortality nor clinical signs were observed in this animal, another animal was treated at the dose of 2000 mg/kg bw.
Main study:
Based on the information obtained in the preliminary study, and since neither mortality nor signs of toxicity were recorded in the female administered at the dose of 2000 mg/kg, the test item was administered orally at the dose of 2000 mg/kg bw to four more animals, making a group of five animals treated in the main study. - No. of animals per sex per dose:
- Preliminary study: 1 animal per dose (300 and 2000 mg/kg bw)
Main study: 5 animals per dose (2000 mg/kg bw) - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations:
* Preliminary study: observations at least twice daily
* Main study: at the day of administration the animals were observed frequently in order to record any possible clinical signs; afterwards the rats were observed at least twice daily for 14 days
- Weighing: before administration, daily on the three following days after treatment, weekly afterwards, and before sacrifice
- Necropsy of survivors performed: yes. At the end of the observation period, all the rats were sacrificed by intraperitoneal injection of sodium pentobarbital and then necropsies were performed on all the animals. This included the inspection of the intact animal and all superficial tissues,
followed by the observation of the viscera of the cranial, thoracic and abdominal cavities.
- Other examinations performed: changes in skin and fur, eyes and mucous membranes, respiratory, circulatory, autonomic and central nervous systems, somatomotor activity and behaviour pattern in order to note any possible clinical response. - Statistics:
- Statistics were performed on body weight (mean weight and standard deviation; see Table 1).
Results and discussion
- Preliminary study:
- Initially, one rat was treated at the dose of 300 mg/kg body weight. As neither mortality nor clinical signs were observed in this animal, another animal was treated at the dose of 2000 mg/kg bw. Piloerection was recorded in this animal from 3-4 hours after the administration. The presence of this clinical sign was not considered enough to confirm that the animal presented evident toxicity. This animal did not present clinical signs on the days following the treatment. No macroscopic alterations were recorded at the necropsies performed on the animals treated at the cited doses.
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- None
- Clinical signs:
- other: None
- Gross pathology:
- No macroscopic alterations were detected during the necropsies done on the animals treated at the dose of 2000 mg/kg bw.
- Other findings:
- N.A.
Any other information on results incl. tables
Table 1: Body weight (g), main study
Dose level (mg/kg) |
Animal number |
Sex |
Day of the observation period |
Weight at necropsy |
|||||
0 |
1 |
2 |
3 |
7 |
14 |
||||
2000 |
2 |
F |
218 |
240 |
235 |
233 |
238 |
253 |
253 |
3 |
F |
221 |
244 |
246 |
248 |
258 |
265 |
265 |
|
4 |
F |
217 |
243 |
245 |
249 |
249 |
251 |
251 |
|
5 |
F |
206 |
222 |
226 |
226 |
228 |
238 |
238 |
|
6 |
F |
211 |
233 |
235 |
235 |
251 |
264 |
264 |
|
Mean |
214.6 |
236.4 |
237.4 |
238.2 |
244.8 |
254.2 |
254.2 |
||
SD |
6.02 |
9.13 |
8.26 |
9.98 |
11.82 |
11.03 |
11.03 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In an acute oral toxicity study conducted according to OECD guideline 420, rats were orally treated with the test item. Based on the results, the LD50 can be considered to be greater than 2000 mg/kg bw.
- Executive summary:
In an acute oral toxicity study conducted according to OECD guideline 420, five female Sprague Dawley SD rats were given a single oral dose of the test item in distilled water at a dose of 2000 mg/kg bw. The animals were observed for 14 days after the single exposure. No clinical signs and no mortalities occurred. Therefore, the oral LD50 can be considered to be greater than 2000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.